These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 19346961)

  • 1. In vivo monitoring of angiogenesis inhibitory treatment effects by dynamic contrast-enhanced computed tomography in a xenograft tumor model.
    Raatschen HJ; Fu Y; Brasch RC; Pietsch H; Shames DM; Yeh BM
    Invest Radiol; 2009 May; 44(5):265-70. PubMed ID: 19346961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initial computed tomography imaging experience using a new macromolecular iodinated contrast medium in experimental breast cancer.
    Simon GH; Fu Y; Berejnoi K; Fournier LS; Lucidi V; Yeh B; Shames DM; Brasch RC
    Invest Radiol; 2005 Sep; 40(9):614-20. PubMed ID: 16118555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a novel macromolecular cascade-polymer contrast medium for dynamic contrast-enhanced MRI monitoring of antiangiogenic bevacizumab therapy in a human melanoma model.
    Cyran CC; Fu Y; Rogut V; Chaopathomkul B; Wendland MF; Shames DM; Brasch RC
    Acad Radiol; 2013 Oct; 20(10):1256-63. PubMed ID: 24029057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of MRI-assayed microvascular permeability on the accumulation of vinorelbine in xenograft tumors].
    Raatschen HJ; Fu Y; Rogut V; Simon GH; Sennino B; Wolf KJ; Brasch RC
    Rofo; 2010 Feb; 182(2):133-9. PubMed ID: 19862658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic contrast-enhanced computed tomography to assess antitumor treatment effects: comparison of two contrast agents with different pharmacokinetics.
    Jost G; Pietsch H; Grenacher L
    Invest Radiol; 2013 Oct; 48(10):715-21. PubMed ID: 23666093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultra-fast carotid CT-angiography: low versus standard volume contrast material protocol for a 128-slice CT-system.
    Hinkmann FM; Voit HL; Anders K; Baum U; Seidensticker P; Bautz WA; Lell MM
    Invest Radiol; 2009 May; 44(5):257-64. PubMed ID: 19550377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decrease in tumor apparent permeability-surface area product to a MRI macromolecular contrast medium following angiogenesis inhibition with correlations to cytotoxic drug accumulation.
    Daldrup-Link HE; Okuhata Y; Wolfe A; Srivastav S; Øie S; Ferrara N; Cohen RL; Shames DM; Brasch RC
    Microcirculation; 2004; 11(5):387-96. PubMed ID: 15280064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New macromolecular polymeric MRI contrast agents for application in the differentiation of cancer from benign soft tissues.
    Cyran CC; Fu Y; Raatschen HJ; Rogut V; Chaopathomkul B; Shames DM; Wendland MF; Yeh BM; Brasch RC
    J Magn Reson Imaging; 2008 Mar; 27(3):581-9. PubMed ID: 18219614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic contrast-enhanced micro-computed tomography correlates with 3-dimensional fluorescence ultramicroscopy in antiangiogenic therapy of breast cancer xenografts.
    Pöschinger T; Renner A; Eisa F; Dobosz M; Strobel S; Weber TG; Brauweiler R; Kalender WA; Scheuer W
    Invest Radiol; 2014 Jul; 49(7):445-56. PubMed ID: 24598441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bevacizumab inhibits breast cancer-induced osteolysis, surrounding soft tissue metastasis, and angiogenesis in rats as visualized by VCT and MRI.
    Bäuerle T; Hilbig H; Bartling S; Kiessling F; Kersten A; Schmitt-Gräff A; Kauczor HU; Delorme S; Berger MR
    Neoplasia; 2008 May; 10(5):511-20. PubMed ID: 18472968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiangiogenic and radiation therapy: early effects on in vivo computed tomography perfusion parameters in human colon cancer xenografts in mice.
    Ren Y; Fleischmann D; Foygel K; Molvin L; Lutz AM; Koong AC; Jeffrey RB; Tian L; Willmann JK
    Invest Radiol; 2012 Jan; 47(1):25-32. PubMed ID: 22178893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular permeability during antiangiogenesis treatment: MR imaging assay results as biomarker for subsequent tumor growth in rats.
    Raatschen HJ; Simon GH; Fu Y; Sennino B; Shames DM; Wendland MF; McDonald DM; Brasch RC
    Radiology; 2008 May; 247(2):391-9. PubMed ID: 18372448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic iodinated contrast agents with PEG-cores for CT imaging: synthesis and preliminary characterization.
    Fu Y; Nitecki DE; Maltby D; Simon GH; Berejnoi K; Raatschen HJ; Yeh BM; Shames DM; Brasch RC
    Bioconjug Chem; 2006; 17(4):1043-56. PubMed ID: 16848414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic contrast-enhanced computed tomography imaging biomarkers correlated with immunohistochemistry for monitoring the effects of sorafenib on experimental prostate carcinomas.
    Cyran CC; von Einem JC; Paprottka PM; Schwarz B; Ingrisch M; Dietrich O; Hinkel R; Bruns CJ; Clevert DA; Eschbach R; Reiser MF; Wintersperger BJ; Nikolaou K
    Invest Radiol; 2012 Jan; 47(1):49-57. PubMed ID: 21934514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive contrast-enhanced US quantitative assessment of tumor microcirculation in a murine model: effect of discontinuing anti-VEGF therapy.
    Guibal A; Taillade L; Mulé S; Comperat E; Badachi Y; Golmard JL; Le Guillou-Buffello D; Rixe O; Bridal SL; Lucidarme O
    Radiology; 2010 Feb; 254(2):420-9. PubMed ID: 20093514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic Contrast-Enhanced Computed Tomography-Derived Blood Volume and Blood Flow Correlate With Patient Outcome in Metastatic Renal Cell Carcinoma.
    Mains JR; Donskov F; Pedersen EM; Madsen HH; Rasmussen F
    Invest Radiol; 2017 Feb; 52(2):103-110. PubMed ID: 27513367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of angiogenesis using micro-computed tomography in a xenograft mouse model of lung cancer.
    Savai R; Langheinrich AC; Schermuly RT; Pullamsetti SS; Dumitrascu R; Traupe H; Rau WS; Seeger W; Grimminger F; Banat GA
    Neoplasia; 2009 Jan; 11(1):48-56. PubMed ID: 19107231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring the effects of anti-angiogenesis on the radiation sensitivity of pancreatic cancer xenografts using dynamic contrast-enhanced computed tomography.
    Cao N; Cao M; Chin-Sinex H; Mendonca M; Ko SC; Stantz KM
    Int J Radiat Oncol Biol Phys; 2014 Feb; 88(2):412-8. PubMed ID: 24411612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic contrast-enhanced micro-CT on mice with mammary carcinoma for the assessment of antiangiogenic therapy response.
    Eisa F; Brauweiler R; Hupfer M; Nowak T; Lotz L; Hoffmann I; Wachter D; Dittrich R; Beckmann MW; Jost G; Pietsch H; Kalender WA
    Eur Radiol; 2012 Apr; 22(4):900-7. PubMed ID: 22071777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI monitoring of tumor response following angiogenesis inhibition in an experimental human breast cancer model.
    Turetschek K; Preda A; Floyd E; Shames DM; Novikov V; Roberts TP; Wood JM; Fu Y; Carter WO; Brasch RC
    Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):448-55. PubMed ID: 12722742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.